SARS-CoV-2 vaccine responses in patients with conditions leading to diminished immune capacity - The OCTAVE and OCTAVE-DUO Trials. (Mini oral presentation) (2022)
Attributed to:
Optimising Vaccine Efficacy in Multi-Disease Patient Cohorts with SARS-CoV-2 vaccine failure (OCTAVE-DUO)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Publication URI: https://markterfolg.de/ESCMID/Final_Programme_2022/#page=64
Type: Conference/Paper/Proceeding/Abstract